OraQuick is the first FDA-approved over-the-counter, rapid in-home HIV test. It provides a private, pain-free way to screen for HIV-1 and HIV-2 antibodies by using an oral swab instead of a blood sample. The test delivers confidential results in 20 minutes.
How to Use the Test
To ensure an accurate reading, you must precisely follow the testing instructions:
-
Preparation: Do not eat, drink, or use oral care products (like toothpaste or mouthwash) for 30 minutes before starting the test. Remove any dental products covering your gums.
-
The Swab: Take the collection stick and gently swipe the flat pad once along your upper gums and once along your lower gums. Do not swab the inside of your cheeks or your tongue.
-
The Development: Insert the pad completely into the provided test tube containing the developer solution. Leave it there to read the results at the 20-minute mark. Do not read the results after 40 minutes.
Understanding Your Results
The testing device features two designated areas: C (Control) and T (Test).
-
Negative Result: A single line appears next to the C and no line appears next to the T. This means HIV antibodies were not detected.
-
Positive Result: Two lines appear, one next to C and one next to T - even if the "T" line is very faint. This is a preliminary positive result and requires a confirmatory medical blood test at a clinic to verify.
-
Invalid Result: If no line appears next to C, the test did not work properly and the result is invalid, meaning you must retest with a new kit.
Important Considerations & Limitations
-
The Window Period: OraQuick looks for the body's immune response (antibodies) to HIV, not the virus itself. It takes time for the body to build up enough antibodies to be detected. Because of this 3-month window period, taking the test too soon after a potential exposure may lead to a false negative. If you think you were exposed recently, you should test again after 3 months.
-
Accuracy: When used correctly, OraQuick has a high specificity rate (about 99.98%), meaning false positives are very rare. However, its sensitivity is around 92%, meaning about 1 in 12 HIV-positive individuals may receive a false negative result, often due to testing within the window period or user error.
-
Exclusions: You should not use this test if you are already known to be HIV-positive, are taking PrEP/PEP preventative treatments, are on HIV treatment, or are participating in an HIV vaccine trial, as these factors will skew the results.
